γδ T lymphocyte responses to HIV

Clinical and Experimental Immunology

Volumn 103, Issue 2, 1996, Pages 177-184

  Wallace, M ^a   Bartz, S R ^a   Chang, W L ^a   Mackenzie, D A ^a   Pauza, C D ^a,b   Malkovsky, M ^a,b  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF WISCONSIN   (United States)

Author keywords

Cytotoxicity; HIV; Proliferation; T lymphocyte

Indexed keywords

T LYMPHOCYTE RECEPTOR;

ADULT; ARTICLE; CELL CLONE; CYTOTOXICITY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE PROLIFERATION; NORMAL HUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

CLONE CELLS; CYTOTOXICITY, IMMUNOLOGIC; HIV INFECTIONS; HIV-1; HUMANS; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES;

EID: 0030038973     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1996.d01-625.x     Document Type: Article

References (65)

1. Dalgleish AG, Malkovsky M. Advances in human retroviruses. Adv Cancer Res 1988; 51:307-60.
2. Fauci AS, Schnittman SM, Poli G et al. Immunopathogenic mechanisms in human immunodeficiency virus (HIV) infection. Ann Intern Med 1991; 114:678-93.
3. Buchbinder SP, Katz MH, Hessol NA et al. Long-term HIV-1 infection without immunologic progression. AIDS 1994; 8:1123-8.
4. Dalgleish AG, Malkovsky M. AIDS and the new viruses. In: Webster ADB, ed. Immunodeficiency and disease. London: Kluwer Academic Publishers, 1988: 1-24.
5. Pantaleo G, Graziosi C, Fauci AS. The immunopathogenesis of human immunodeficiency virus infection. N Engl J Med 1993; 328:327-35.
6. Daar ES, Moudgil T, Meyer RD, Ho DD. Transient high levels of viremia in patients with primary human immunodeficiency virus type 1 infection. N Engl J Med 1991; 324:961-4.
7. Graziosi C, Pantaleo G, Butini L et al. Kinetics of human immunodeficiency virus type 1 (HIV-1) DNA and RNA synthesis during primary HIV-1 infection. Proc Natl Acad Sci USA 1993; 90:6405-9.
8. + cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. J Virol 1994; 68:6103-10.
9. Safrit JT, Andrews CA, Zhu T et al. Characterization of human immunodeficiency virus type 1-specific cytotoxic T lymphocyte clones isolated during acute seroconversion: recognition of autologous virus sequences within a conserved immunodominant epitope. J Exp Med 1994; 179:463-72.
10. Lanier LL, Ruitemberg J, Bolhuis RHL et al. Structural and serological heterogeneity of γδ T cell antigen receptor expression in thymus and peripheral blood. Eur J Immunol 1988; 18:1985-92.
11. Bottino C, Tambussi G, Ferrini S et al. Two subsets of human T lymphocytes expressing γ/δ antigen receptor are identifiable by monoclonal antibodies directed to two distinct molecular forms of the receptor. J Exp Med 1988; 168:491-505.
12. Faure F, Jitsukawa S, Triebel F, Hercend T. Characterization of human peripheral lymphocytes expressing the CD3-γ/δ complex with anti-receptor monoclonal antibodies. J Immunol 1988; 141:3357-60.
13. Modlin RL, Pirmez C, Horman FM et al. Lymphocytes bearing antigen-specific γ/δ T cell receptors accumulate in human infectious disease lesions. Nature 1989; 339:544-8.
14. Bertotto A, Gerli R, Spinozzi F et al. Lymphocytes bearing the γδ T cell receptor in acute Brucella melitensis infection. Eur J Immunol 1993; 23:1177-80.
15. Roussilhon C, Agrapart M, Ballet J-J, Bensussan A. T lymphocytes bearing the γδ T cell receptor in patients with acute Plasmodium falciparum malaria. J Inf Dis 1990; 162:283-5.
16. Russo DM, Armitage RJ, Barral-Netto M et al. Antigen-reactive γδ T cells in human leishmaniasis. J Immunol 1993; 151:3712-8.
17. De Paoli P, Basaglia G, Gennari D et al. Phenotypic profile and functional characteristics of human gamma and delta T cells during acute toxoplasmosis. J Clin Microbiol 1992; 30:729-31.
18. Wallace M, Malkovsky M, Carding S. Gamma/delta T lymphocytes in viral infections. J Leuk Biol 1995; 58:277-83.
19. De Paoli P, Gennari D, Martelli P et al. γδ T cell receptor-bearing lymphocytes during Epstein-Barr virus infection. J Inf Dis 1990; 161:1013-6.
20. Maccario R, Revello MG, Comoli P et al. HLA-unrestricted killing of HSV-1 infected mononuclear cells. J Immunol 1993; 150:1437-45.
21. Bukowski JF, Morita CT, Brenner MB. Recognition and destruction of virus-infected cells by human γδ CTL. J Immunol 1994; 153:5133-40.
22. De Paoli P, Gennari D, Martelli P et al. A subset of γδ T lymphocytes is increased during HIV-1 infection. Clin Exp Immunol 1991; 83:187-91.
23. De Maria A, Ferrazin A, Ferrini S et al. Selective increase of a subset of T cell receptor γδ T lymphocytes in the peripheral blood of patients with human immunodeficiency virus type 1 infection. J Inf Dis 1991; 165:917-9.
24. + lymphocyte subsets during HIV infection. Clin Exp Immunol 1989; 75:206-10.
25. Band H, Hochstenbach F, McLean J et al. Immunological proof that a novel rearranging gene encodes the T cell receptor delta subunit. Science 1987; 238:682-4.
26. - T lymphocytes. Eur J Immunol 1989; 19:57-61.
27. - lymphocytes to express their functional program(s). J Exp Med 1988; 168:1-11.
28. Ivanyi J, Sinha S, Aston R et al. Definition of species specific and crossreactive antigenic determinants of Mycobacterium leprae using monoclonal antibodies. Clin Exp Immunol 1983; 52:528-36.
29. Fisch P, Malkovsky M, Kovats S et al. Recognition by human Vγ9/Vδ2 T cells of a GroEL homolog on Daudi Burkitt's lymphoma cells. Science 1990; 250:1269-73.
30. Foley GE, Lazarus H, Farber S et al. Continuous culture of human lymphoblasts from peripheral blood of a child with acute leukemia. Cancer 1965; 18:522-9.
31. Hoxie JA, Haggarty BS, Bonser SE et al. Biological characterization of a simian immunodeficiency virus-like retrovirus (HTLV-1V): evidence for CD4-associated molecules required for infection. J Virol 1988; 62:2557-68.
32. Klein E, Klein G, Nadkarni JS et al. Surface IgM-kappa specificity on a Burkitt lymphoma cell in vivo and in derived culture lines. Cancer Res 1968; 28:1300-10.
33. Pulvertaft RJV. Cytology of Burkitt's tumour (African lymphoma). Lancet 1964; i:238-40.
34. Alizon M, Sonigo P, Barre-Sinoussi F et al. Molecular cloning of lymphadenopathy-associated virus. Nature 1984; 312:757-60.
35. Bartz SR, Hohenwalter E, Hu M-K. et al. Inhibition of HIV-1 replication by nonimmunosuppressive analogs of cyclosporin A. Proc Natl Acad Sci USA 1995; 92:5381-5.
36. + cells during HIV infection by flow cytometry. AIDS 1992; 6:1121-5.
37. Malkovsky M, Dore C, Hunt R et al. Enhancement of specific antitumour immunity in mice fed a diet enriched in vitamin A acetate. Proc Natl Acad Sci USA 1993; 80:6322-6.
38. Bartz SR, Pauza CD, Ivanyi J et al. An hsp60 related protein is associated with purified HIV and SIV. J Med Primatol 1994; 23:151-4.
39. + lymphocytes in resistance to mucosal candidiasis. Infect Immun 1991; 59:2447-55.
40. Malkovsky M, Asherson GL, Stockinger B, Watkins MC. Non-specific inhibitor released by T acceptor cells reduces the production of interleukin-2. Nature 1982; 300:652-5.
41. Fisch P, Malkovsky M, Braakman E et al. γδ T cell clones and natural killer cell clones mediate distinct patterns of non-major histocompatibility complex-restricted cytolysis. J Exp Med 1990; 171:1567-79.
42. Arthur LO, Bess JW, Jr, Sowder RCH et al. Cellular proteins bound to immunodeficiency viruses: implications for pathogenesis and vaccines. Science 1992; 258:1935-8.
43. Malkovsky M. The function and specificity of γδ T cells. Vaccine Res 1992; 1:183-91.
44. Malkovsky M, Bartz SR, MacKenzie D et al. Are γδ T cells important for the elimination of virus-infected cells? J Med Primatol 1992; 21:113-8.
45. Wallace M, Gan Y-H, Pauza CD et al. Antiviral activity of primate γδ T lymphocytes isolated by magnetic cell sorting. J Med Primatol 1994; 23:131-5.
46. Kabelitz D, Pechhold K, Bender A et al. Activation and activation-driven death of human γδ T cells. Immunol Rev 1991; 120:71-88.
47. + T cells in peripheral blood of children with perinatal human immunodeficiency virus (HIV) infection. J Clin Immunol 1993; 13: 193-203.
48. Lusso P, Garzino-Demo A, Crowley RW et al. Infection of γδ T lymphocytes by human herpesvirus 6: transcriptional induction of CD4 and susceptibility to HIV infection. J Exp Med 1995; 181:1303-10.
49. Janeway CA Jr, Jones B, Hayday A. Specificity and function of T cells bearing γδ receptors. Immunol Today 1988; 9:73-76.
50. Ananthan J, Goldberg AL, Voellmy R. Abnormal proteins serve as eukaryotic stress signals and trigger the activation of heat shock genes. Science 1986; 232:522-4.
51. Jindal S, Malkovsky M. Stress responses to viral infection. Trends Microbiol 1994; 2:89-91.
52. Notarianni EL, Preston CM. Activation of cellular stress protein genes by herpes simplex virus temperature-sensitive mutants which overproduce immediate early polypeptides. Virology 1982; 123: 113-22.
53. LaThangue NB, Shriver K, Dawson C, Chan WL. Herpes simplex virus infection causes the accumulation of a heat-shock protein. EMBO J 1984; 3:267-77.
54. Kennedy PGE, LaThangue NB, Chan WL, Clements GB. Cultured human neural cells accumulate a heat-shock protein during acute herpes virus infection. Neuroscience Letters 1985; 61:321-6.
55. Macnab JCM, Orr A, LaThangue NB. Cellular proteins expressed in herpes simplex virus transformed cells also accumulate in herpes simplex virus infection. EMBO J 1985; 4:3223-8.
56. Patel R, Chan WL, Kemp LM, LaThangue NB, Latchman DS. Isolation of cDNA clones derived from a cellular gene transcriptionally induced by herpes simplex virus. Nucleic Acids Res 1986; 14:5629-40.
57. Russell J, Stow EC, Stow ND, Preston CM. Abnormal forms of the herpes simplex virus immediate early polypeptide Vmw175 induce the cellular stress response. J Gen Virol 1987; 68:2397-406.
58. LaThangue NB, Latchman DS. Nuclear accumulation of a heat-shock 70-like protein during herpes simplex virus replication. Bioscience Reports 1987; 7:475-83.
59. LaThangue NB, Latchman DS. A cellular protein related to heat-shock protein 90 accumulates during herpes simplex virus infection and is overexpressed in transformed cells. Exp Cell Res 1988; 178: 169-79.
60. Tanaka Y, Sano S, Nieves E et al. Nonpeptide ligands for human γδ T cells. Proc Natl Acad Sci USA 1994; 91:8175-9.
61. Constant P, Davodeau F, Peyrat M-A et al. Stimulation of human γδ T cells by nonpeptidic mycobacterial ligands. Science 1994; 264: 267-70.
62. Schoel B, Sprenger S, Kaufmann SHE. Phosphate is essential for stimulation of Vγ9/Vδ2 lymphocytes by mycobacterial low molecular weight ligand. Eur J Immunol 1994; 24:1886-92.
63. Bukowski JF, Morita CT, Tanaka Y et al. Vγ2Vδ2 TCR-dependent recognition of non-peptide antigens and Daudi cells analyzed by TCR gene transfer. J Immunol 1995; 154:998-1006.
64. Tanaka Y, Morita CT, Tanaka Y et al. Natural and synthetic nonpeptide antigens recognized by human γδ T cells. Nature 1995; 375:155-8.
65. Dalgleish AG. The immune response to HIV: potential for immunotherapy? Immunol Today 1995; 16:356-8.